A Phase I Study of the Anti-CD79b Antibody-Drug Conjugate (ADC) DCDS4501A Targeting CD79b in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma (NHL) 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) Palanca-Wessels, M. C., Flinn, I. W., Sehn, L. H., Patel, M., Sangha, R., Czuczman, M. S., Salles, G. A., Morschhauser, F., Advani, R., Press, O. W., Ho, W., Kahn, R., Lu, D., Su, Z., Chu, Y., Assouline, S. E. AMER SOC HEMATOLOGY. 2012

View details for Web of Science ID 000313838900108